AN2 Therapeutics
ANTX
ANTX
31 hedge funds and large institutions have $99.9M invested in AN2 Therapeutics in 2023 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 3 increasing their positions, 16 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
81% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 16
Holders
31
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$11M | |
| 2 | +$8.59M | |
| 3 | +$6.13M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$425K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$387K |
Top Sellers
| 1 | -$3.91M | |
| 2 | -$782K | |
| 3 | -$751K | |
| 4 |
State Street
Boston,
Massachusetts
|
-$670K |
| 5 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$561K |